These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

916 related articles for article (PubMed ID: 22634756)

  • 21. The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patients.
    Jiang Z; Jhunjhunwala S; Liu J; Haverty PM; Kennemer MI; Guan Y; Lee W; Carnevali P; Stinson J; Johnson S; Diao J; Yeung S; Jubb A; Ye W; Wu TD; Kapadia SB; de Sauvage FJ; Gentleman RC; Stern HM; Seshagiri S; Pant KP; Modrusan Z; Ballinger DG; Zhang Z
    Genome Res; 2012 Apr; 22(4):593-601. PubMed ID: 22267523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Geographic characterization of hepatitis virus infections, genotyping of hepatitis B virus, and p53 mutation in hepatocellular carcinoma analyzed by in situ detection of viral genomes from carcinoma tissues: comparison among six different countries.
    Ding X; Park YN; Taltavull TC; Thung SN; Jin X; Jin Y; Trung NS; Edamoto Y; Sata T; Abe K
    Jpn J Infect Dis; 2003 Feb; 56(1):12-8. PubMed ID: 12711820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections.
    Tornesello ML; Buonaguro L; Tatangelo F; Botti G; Izzo F; Buonaguro FM
    Genomics; 2013 Aug; 102(2):74-83. PubMed ID: 23583669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NGS-based profiling reveals a critical contributing role of somatic D-loop mtDNA mutations in HBV-related hepatocarcinogenesis.
    Yin C; Li DY; Guo X; Cao HY; Chen YB; Zhou F; Ge NJ; Liu Y; Guo SS; Zhao Z; Yang HS; Xing JL
    Ann Oncol; 2019 Jun; 30(6):953-962. PubMed ID: 30887045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma.
    Kan Z; Zheng H; Liu X; Li S; Barber TD; Gong Z; Gao H; Hao K; Willard MD; Xu J; Hauptschein R; Rejto PA; Fernandez J; Wang G; Zhang Q; Wang B; Chen R; Wang J; Lee NP; Zhou W; Lin Z; Peng Z; Yi K; Chen S; Li L; Fan X; Yang J; Ye R; Ju J; Wang K; Estrella H; Deng S; Wei P; Qiu M; Wulur IH; Liu J; Ehsani ME; Zhang C; Loboda A; Sung WK; Aggarwal A; Poon RT; Fan ST; Wang J; Hardwick J; Reinhard C; Dai H; Li Y; Luk JM; Mao M
    Genome Res; 2013 Sep; 23(9):1422-33. PubMed ID: 23788652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma.
    Li M; Zhao H; Zhang X; Wood LD; Anders RA; Choti MA; Pawlik TM; Daniel HD; Kannangai R; Offerhaus GJ; Velculescu VE; Wang L; Zhou S; Vogelstein B; Hruban RH; Papadopoulos N; Cai J; Torbenson MS; Kinzler KW
    Nat Genet; 2011 Aug; 43(9):828-9. PubMed ID: 21822264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular aspects of hepatic carcinogenesis.
    Nita ME; Alves VA; Carrilho FJ; Ono-Nita SK; Mello ES; Gama-Rodrigues JJ
    Rev Inst Med Trop Sao Paulo; 2002; 44(1):39-48. PubMed ID: 11896411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HBV genome integration and genetic instability in HBsAg-negative and anti-HCV-positive hepatocellular carcinoma in Japan.
    Matsuzaki Y; Chiba T; Hadama T; Asaoka H; Doy M; Shoda J; Tanaka N; Kinoshita M
    Cancer Lett; 1997 Oct; 119(1):53-61. PubMed ID: 18372522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppression of PROX1-mediated TERT expression in hepatitis B viral hepatocellular carcinoma.
    Kim YJ; Yoo JE; Jeon Y; Chong JU; Choi GH; Song DG; Jung SH; Oh BK; Park YN
    Int J Cancer; 2018 Dec; 143(12):3155-3168. PubMed ID: 29987895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A pilot systematic genomic comparison of recurrence risks of hepatitis B virus-associated hepatocellular carcinoma with low- and high-degree liver fibrosis.
    Yoo S; Wang W; Wang Q; Fiel MI; Lee E; Hiotis SP; Zhu J
    BMC Med; 2017 Dec; 15(1):214. PubMed ID: 29212479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene copy number variations in the leukocyte genome of hepatocellular carcinoma patients with integrated hepatitis B virus DNA.
    Pang Y; Guo W; Wang J; Xu G; Cheng K; Cao G; Wu M; Cheng S; Liu S
    Oncotarget; 2016 Feb; 7(7):8006-18. PubMed ID: 26769853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diverse modes of genomic alteration in hepatocellular carcinoma.
    Jhunjhunwala S; Jiang Z; Stawiski EW; Gnad F; Liu J; Mayba O; Du P; Diao J; Johnson S; Wong KF; Gao Z; Li Y; Wu TD; Kapadia SB; Modrusan Z; French DM; Luk JM; Seshagiri S; Zhang Z
    Genome Biol; 2014 Aug; 15(8):436. PubMed ID: 25159915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression.
    Okabe H; Satoh S; Kato T; Kitahara O; Yanagawa R; Yamaoka Y; Tsunoda T; Furukawa Y; Nakamura Y
    Cancer Res; 2001 Mar; 61(5):2129-37. PubMed ID: 11280777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan.
    Tamori A; Nishiguchi S; Kubo S; Narimatsu T; Habu D; Takeda T; Hirohashi K; Shiomi S
    J Med Virol; 2003 Dec; 71(4):492-8. PubMed ID: 14556260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integration of hepatitis B virus containing mutations in the core promoter/X gene in patients with hepatocellular carcinoma.
    Momosaki S; Hsia CC; Nakashima Y; Kojiro M; Tabor E
    Dig Liver Dis; 2003 Nov; 35(11):795-800. PubMed ID: 14674670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Somatic mutations at the trinucleotide repeats of androgen receptor gene in male hepatocellular carcinoma.
    Yeh SH; Chiu CM; Chen CL; Lu SF; Hsu HC; Chen DS; Chen PJ
    Int J Cancer; 2007 Apr; 120(8):1610-7. PubMed ID: 17230529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular alterations in hepatocellular carcinoma associated with hepatitis B and hepatitis C infections.
    Tornesello ML; Buonaguro L; Izzo F; Buonaguro FM
    Oncotarget; 2016 May; 7(18):25087-102. PubMed ID: 26943571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Whole-genome mutational landscape of liver cancers displaying biliary phenotype reveals hepatitis impact and molecular diversity.
    Fujimoto A; Furuta M; Shiraishi Y; Gotoh K; Kawakami Y; Arihiro K; Nakamura T; Ueno M; Ariizumi S; Nguyen HH; Shigemizu D; Abe T; Boroevich KA; Nakano K; Sasaki A; Kitada R; Maejima K; Yamamoto Y; Tanaka H; Shibuya T; Shibata T; Ojima H; Shimada K; Hayami S; Shigekawa Y; Aikata H; Ohdan H; Marubashi S; Yamada T; Kubo M; Hirano S; Ishikawa O; Yamamoto M; Yamaue H; Chayama K; Miyano S; Tsunoda T; Nakagawa H
    Nat Commun; 2015 Jan; 6():6120. PubMed ID: 25636086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variable Intra-Tumor Genomic Heterogeneity of Multiple Lesions in Patients With Hepatocellular Carcinoma.
    Xue R; Li R; Guo H; Guo L; Su Z; Ni X; Qi L; Zhang T; Li Q; Zhang Z; Xie XS; Bai F; Zhang N
    Gastroenterology; 2016 Apr; 150(4):998-1008. PubMed ID: 26752112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive analysis of genetic aberrations linked to tumorigenesis in regenerative nodules of liver cirrhosis.
    Kim SK; Takeda H; Takai A; Matsumoto T; Kakiuchi N; Yokoyama A; Yoshida K; Kaido T; Uemoto S; Minamiguchi S; Haga H; Shiraishi Y; Miyano S; Seno H; Ogawa S; Marusawa H
    J Gastroenterol; 2019 Jul; 54(7):628-640. PubMed ID: 30756187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.